545
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy

, , , , , , ORCID Icon & show all
Pages 1949-1964 | Received 18 Nov 2022, Accepted 01 Apr 2023, Published online: 11 Apr 2023

References

  • Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
  • Vinod S, Hau E. Radiotherapy treatment for lung cancer: current status and future directions. Respirology. 2020;25(S2):61–71. doi:10.1111/resp.13870
  • Batooei S, Khajeali A, Khodadadi R, Pirayesh Islamian J. Metal-based nanoparticles as radio-sensitizer in gastric cancer therapy. J Drug Deliv Sci Technol. 2020;56:101576. doi:10.1016/j.jddst.2020.101576
  • Chen Y, Yang J, Fu S, Wu J. Gold nanoparticles as radiosensitizers in cancer radiotherapy. Int J Nanomedicine. 2020;15:9407–9430. doi:10.2147/ijn.S272902
  • Liu Y, Zhang P, Li F, et al. NanoEnhancersMetal-based for future radiotherapy: radiosensitizing and synergistic effects on tumor cells. RSC Adv. 2018;8(7):1824–1849. doi:10.7150/thno.22172
  • Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater. 2017;29(32):1700996. doi:10.1002/adma.201700996
  • Choi J, Kim G, Cho S, Im H. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme. J Nanobiotechnology. 2020;18(1):122. doi:10.1186/s12951-020-00684-5
  • Zhang Y, Sriramaneni R, Clark P, et al. Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade. Nat Commun. 2022;13(1):4948. doi:10.1038/s41467-022-32645-x
  • Alyani Nezhad Z, Geraily G, Hataminia F, Parwaie W, Ghanbari H, Gholami S. Bismuth oxide nanoparticles as agents of radiation dose enhancement in intraoperative radiotherapy. Med Phys. 2021;48(3):1417–1426. doi:10.1002/mp.14697
  • Qin X, Yang C, Xu H, et al. Cell-derived biogenetic gold nanoparticles for sensitizing radiotherapy and boosting immune response against cancer. Small. 2021;17(50):e2103984. doi:10.1002/smll.202103984
  • Yang C, Gao Y, Fan Y, et al. Dual-mode endogenous and exogenous sensitization of tumor radiotherapy through antifouling dendrimer-entrapped gold nanoparticles. Theranostics. 2021;11(4):1721–1731. doi:10.7150/thno.54930
  • Huo D, Liu S, Zhang C, et al. Hypoxia-targeting, tumor microenvironment responsive nanocluster bomb for radical-enhanced radiotherapy. ACS Nano. 2017;11(10):10159–10174. doi:10.1021/acsnano.7b04737
  • Ji C, Zhao M, Wang C, et al. Biocompatible tantalum nanoparticles as radiosensitizers for enhancing therapy efficacy in primary tumor and metastatic sentinel lymph nodes. ACS Nano. 2022;16(6):9428–9441. doi:10.1021/acsnano.2c02314
  • Peng C, Liang Y, Su N, et al. Dual nanoenzymes loaded hollow mesoporous organotantalum nanospheres for chemo-radio sensitization. J Control Release. 2022;347:369–378. doi:10.1016/j.jconrel.2022.05.018
  • Song G, Chen Y, Liang C, et al. Catalase-loaded TaOx nanoshells as bio-nanoreactors combining high-Z element and enzyme delivery for enhancing radiotherapy. Adv Mater. 2016;28(33):7143–7148. doi:10.1002/adma.201602111
  • Chen Y, Song G, Dong Z, et al. Drug-loaded mesoporous tantalum oxide nanoparticles for enhanced synergetic chemoradiotherapy with reduced systemic toxicity. Small. 2017;13(8). doi:10.1002/smll.201602869
  • Zhang P, Marill J, Darmon A, Mohamed Anesary N, Lu B, Paris S. NBTXR3 radiotherapy-activated functionalized hafnium oxide nanoparticles show efficient antitumor effects across a large panel of human cancer models. Int J Nanomedicine. 2021;16:2761–2773. doi:10.2147/ijn.S301182
  • Zhao J, Liu P, Ma J, et al. Enhancement of radiosensitization by silver nanoparticles functionalized with polyethylene glycol and aptamer As1411 for glioma irradiation therapy. Int J Nanomedicine. 2019;14:9483–9496. doi:10.2147/ijn.S224160
  • Tremi I, Spyratou E, Souli M, et al. Requirements for designing an effective metallic Nanoparticle (NP)-Boosted Radiation Therapy (RT). Cancers. 2021;13(13):3185. doi:10.3390/cancers13133185
  • Cui L, Her S, Borst G, Bristow R, Jaffray D, Allen C. Radiosensitization by gold nanoparticles: will they ever make it to the clinic? Radiother Oncol. 2017;124(3):344–356. doi:10.1016/j.radonc.2017.07.007
  • Dimitriou N, Tsekenis G, Balanikas E, et al. Gold nanoparticles, radiations and the immune system: current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol Ther. 2017;178:1–17. doi:10.1016/j.pharmthera.2017.03.006
  • Her S, Jaffray D, Allen C. Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements. Adv Drug Deliv Rev. 2017;109:84–101. doi:10.1016/j.addr.2015.12.012
  • Silva F, Paulo A, Pallier A, et al. Dual imaging gold nanoplatforms for targeted radiotheranostics. Materials. 2020;13(3):513. doi:10.3390/ma13030513
  • Schuemann J, Berbeco R, Chithrani D, et al. Roadmap to clinical use of gold nanoparticles for radiation sensitization. Int J Radiat Oncol Biol Phys. 2016;94(1):189–205. doi:10.1016/j.ijrobp.2015.09.032
  • Dobešová L, Gier T, Kopečná O, et al. Incorporation of low concentrations of gold nanoparticles: complex effects on radiation response and fate of cancer cells. Pharmaceutics. 2022;14(1):166. doi:10.3390/pharmaceutics14010166
  • Kempson I. Mechanisms of nanoparticle radiosensitization. Wiley Interdiscip Rev. 2021;13(1):e1656. doi:10.1002/wnan.1656
  • Tremi I, Havaki S, Georgitsopoulou S, et al. Biological response of human cancer cells to ionizing radiation in combination with gold nanoparticles. Cancers. 2022;14(20):5086. doi:10.3390/cancers14205086
  • Karimi M, Bahrami S, Ravari S, et al. Albumin nanostructures as advanced drug delivery systems. Expert Opin Drug Deliv. 2016;13(11):1609–1623. doi:10.1080/17425247.2016.1193149
  • Misak H, Asmatulu R, Gopu J, et al. Albumin-based nanocomposite spheres for advanced drug delivery systems. Biotechnol J. 2014;9(1):163–170. doi:10.1002/biot.201300150
  • Jahanban-Esfahlan A, Dastmalchi S, Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol. 2016;91:703–709. doi:10.1016/j.ijbiomac.2016.05.032
  • Tang X, Wang G, Shi R, et al. Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles. Drug Deliv. 2016;23(8):2686–2696. doi:10.3109/10717544.2015.1049720
  • Van de Sande L, Cosyns S, Willaert W, Ceelen W. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review. Drug Deliv. 2020;27(1):40–53. doi:10.1080/10717544.2019.1704945
  • An F, Zhang X. Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery. Theranostics. 2017;7(15):3667–3689. doi:10.7150/thno.19365
  • Lin T, Zhao P, Jiang Y, et al. Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano. 2016;10(11):9999–10012. doi:10.1021/acsnano.6b04268
  • Liu S, Piao J, Liu Y, et al. Radiosensitizing effects of different size bovine serum albumin-templated gold nanoparticles on H22 hepatoma-bearing mice. Nanomedicine. 2018;13(11):1371–1383. doi:10.2217/nnm-2018-0059
  • Bolaños K, Kogan M, Araya E. Capping gold nanoparticles with albumin to improve their biomedical properties. Int J Nanomedicine. 2019;14:6387–6406. doi:10.2147/ijn.S210992
  • Zhang Y, Huang F, Ren C, et al. Enhanced radiosensitization by gold nanoparticles with acid-triggered aggregation in cancer radiotherapy. Adv Sci. 2019;6(8):1801806. doi:10.1002/advs.201801806
  • Goswami N, Luo Z, Yuan X, Leong DT, Xie J. Engineering gold-based radiosensitizers for cancer radiotherapy. Mater Horiz. 2017;4(5):817–831. doi:10.1039/c7mh00451f
  • Zhen W, Weichselbaum R, Lin W. Nanoparticle-mediated radiotherapy remodels the tumor microenvironment to enhance antitumor efficacy. Adv Mater. 2022;e2206370. doi:10.1002/adma.202206370
  • Alle M, Sharma G, Lee S, Kim J. Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives. J Nanobiotechnology. 2022;20(1):222. doi:10.1186/s12951-022-01402-z
  • Wen S, Ovais M, Li X, et al. Tailoring bismuth-based nanoparticles for enhanced radiosensitivity in cancer therapy. Nanoscale. 2022;14(23):8245–8254. doi:10.1039/d2nr01500e
  • Luan S, Xie R, Yang Y, et al. Acid-responsive aggregated gold nanoparticles for radiosensitization and synergistic chemoradiotherapy in the treatment of esophageal cancer. Small. 2022;18(19):e2200115. doi:10.1002/smll.202200115
  • Yu Y, Yang T, Sun T. New insights into the synthesis, toxicity and applications of gold nanoparticles in CT imaging and treatment of cancer. Nanomedicine. 2020;15(11):1127–1145. doi:10.2217/nnm-2019-0395
  • Wei J, Li P, Zhang H, Zhu R. Preparation of BSA-coated Au nanoparticles contrast agent and its application in PETCT imaging. Cell Mol Biol. 2022;68(3):158–170. doi:10.14715/cmb/2022.68.3.19
  • López-Valverde J, Jiménez-Ortega E, Leal A. Clinical feasibility study of gold nanoparticles as theragnostic agents for precision radiotherapy. Biomedicines. 2022;10(5):1214. doi:10.3390/biomedicines10051214
  • Haume K, Rosa S, Grellet S, et al. Gold nanoparticles for cancer radiotherapy: a review. Cancer Nanotechnol. 2016;7(1):8. doi:10.1186/s12645-016-0021-x
  • Al-Abd A, Aljehani Z, Gazzaz R, et al. Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors. J Control Release. 2015;219:269–277. doi:10.1016/j.jconrel.2015.08.055
  • Chen Q, Feng L, Liu J, et al. Intelligent albumin-MnO2 nanoparticles as pH-/H2 O2 -responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy. Adv Mater. 2016;28(33):7129–7136. doi:10.1002/adma.201601902
  • Wang Y, Yang T, Ke H, et al. Smart albumin-biomineralized nanocomposites for multimodal imaging and photothermal tumor ablation. Adv Mater. 2015;27(26):3874–3882. doi:10.1002/adma.201500229
  • Paul M, Itoo A, Ghosh B, Biswas S. Current trends in the use of human serum albumin for drug delivery in cancer. Expert Opin Drug Deliv. 2022;19(11):1449–1470. doi:10.1080/17425247.2022.2134341
  • Cho H, Jeon S, Ahn C, Shim M, Kim K. Emerging albumin-binding anticancer drugs for tumor-targeted drug delivery: current understandings and clinical translation. Pharmaceutics. 2022;14(4):728. doi:10.3390/pharmaceutics14040728
  • Wang H, Wu J, Xu L, Xie K, Chen C, Dong Y. Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity. Chem Commun. 2017;53(17):2618–2621. doi:10.1039/c6cc08978j